This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
OKYO Pharma 관리
관리 기준 확인 1/4
주요 정보
Gary Jacob
최고 경영자
UK£1.5m
총 보상
| CEO 급여 비율 | 17.5% |
| CEO 임기 | 2.3yrs |
| CEO 소유권 | 0.05% |
| 경영진 평균 재임 기간 | 2.3yrs |
| 이사회 평균 재임 기간 | 2.3yrs |
최근 관리 업데이트
Recent updates
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?
Nov 26
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?
Jan 27Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation
Sep 22We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth
Mar 17We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow
Dec 02CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -UK£7m |
| Jun 30 2022 | n/a | n/a | -UK£5m |
| Mar 31 2022 | UK£1m | UK£256k | -UK£4m |
| Dec 31 2021 | n/a | n/a | -UK£4m |
| Sep 30 2021 | n/a | n/a | -UK£4m |
| Jun 30 2021 | n/a | n/a | -UK£3m |
| Mar 31 2021 | UK£649k | UK£61k | -UK£3m |
보상 대 시장: Gary's total compensation ($USD1.82M) is above average for companies of similar size in the UK market ($USD352.33K).
보상과 수익: Gary's compensation has increased whilst the company is unprofitable.
CEO
Gary Jacob (75 yo)
2.3yrs
테뉴어
UK£1,467,000
보상
Dr. Gary S. Jacob, PhD, served as an Independent Director at Virpax Pharmaceuticals, Inc. since April 2020 until July 25, 2022. He had been an Independent Director of Cardiff Oncology, Inc. since February...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Executive Director | 2.3yrs | UK£1.47m | 0.049% £ 11.4k | |
| Founder | no data | 데이터 없음 | 데이터 없음 | |
| Chief Financial Officer | 2.8yrs | 데이터 없음 | 0% £ 0 | |
| Chief Scientific Officer | 2.2yrs | 데이터 없음 | 0% £ 0 |
2.3yrs
평균 재임 기간
64yo
평균 연령
경험이 풍부한 관리: OKYO's management team is considered experienced (2.3 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Executive Director | 2.3yrs | UK£1.47m | 0.049% £ 11.4k | |
| Independent Non-Executive Director | 1.4yrs | UK£14.00k | 데이터 없음 | |
| Non-Executive Chairman | 2.3yrs | UK£120.00k | 33.47% £ 7.8m | |
| Independent Non-Executive Director | 2.9yrs | UK£55.00k | 0% £ 0 | |
| Member of Scientific Advisory Board | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Independent Non-Executive Director | 7.5yrs | UK£35.00k | 0.019% £ 4.3k | |
| Member of Scientific Advisory Board | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 |
2.3yrs
평균 재임 기간
71yo
평균 연령
경험이 풍부한 이사회: OKYO's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.